← Back to feed Culture & Ideas

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

MIT Technology Review 10 April 2026 57m ago
What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma
70
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
12/15
Depth
6/15
Relevance Freshness Authority Brand Depth
Is it the Department of Defense or the Department of War? The Gulf of Mexico or the Gulf of America? A vaccine—or an “individualized neoantigen treatment”? That’s the Trump-era vocabulary paradox facing Moderna, the covid-19 shot maker whose plans for next-generation mRNA vaccines against flus and emerging pathogens have been dashed by vaccine skeptics in…
Read Full Article → MIT Technology Review ↗